Elevated levels of soluble ST2 but not galectin-3 are associated with increased risk of mortality in hemodialysis patients
Background The soluble forms of suppression of tumorigenicity-2 (ST2) and galectin-3 have been proposed as novel biomarkers for cardiac fibrosis and heart failure, as well as predictors of cardiovascular events and mortality. However, there are limited data on the association between soluble ST2 and...
Main Authors: | Ae Jin Kim, Han Ro, Hyunsook Kim, Kwang-Pil Ko, Jae Hyun Chang, Hyun Hee Lee, Wookyung Chung, Ji Yong Jung |
---|---|
Format: | Article |
Language: | English |
Published: |
The Korean Society of Nephrology
2021-03-01
|
Series: | Kidney Research and Clinical Practice |
Subjects: | |
Online Access: | http://www.krcp-ksn.org/upload/pdf/j-krcp-20-133.pdf |
Similar Items
-
Galectin-3 Interacts with Vascular Cell Adhesion Molecule-1 to Increase Cardiovascular Mortality in Hemodialysis Patients
by: Wen-Chin Ko, et al.
Published: (2018-09-01) -
The Role of Galectin-3 and ST2 in Cardiology: A Short Review
by: Ana Merino-Merino, et al.
Published: (2021-08-01) -
Combining Pulse Wave Velocity With Galectin-3 to Predict Mortality and Cerebrovascular and Cardiovascular Events in Hemodialysis Patients
by: Qi Zhang, et al.
Published: (2020-10-01) -
Effect of galectin-3 in the pathogenesis of arteriovenous fistula stenosis formation
by: Lin Ruan, et al.
Published: (2021-01-01) -
Relationship between Circulating Galectin-3, Systemic Inflammation, and Protein-Energy Wasting in Chronic Hemodialysis Patients
by: Ming-Tsun Tsai, et al.
Published: (2021-08-01)